Definition of EGFRvIII. Meaning of EGFRvIII. Synonyms of EGFRvIII

Here you will find one or more explanations in English for the word EGFRvIII. Also in the bottom left of the page several parts of wikipedia pages related to the word EGFRvIII and, of course, EGFRvIII synonyms and on the right images related to the word EGFRvIII.

Definition of EGFRvIII

No result for EGFRvIII. Showing similar results...

Meaning of EGFRvIII from wikipedia

- uncontrolled cell division. In glioblastoma a specific mutation of EGFR, called EGFRvIII, is often observed. Mutations, amplifications or misregulations of EGFR...
- called EGFRvIII present in about 25% to 30% of glioblastoma cases. The vaccine consists of the EGFRv3-specific peptide (a 13-amino acid mutant vIII epitope)...
- rRNA-minus RNA-seq. egfr-v3-determiner EGFR-v3-determiner is a tool that counts EGFRvIII and EGFRwt splice/structural variant directly from alignment files. FusionAnalyser...
- microbubbles to increase BBB permeability and allow GBM tumor biomarkers (EGFRvIII and TERT C228T) to p**** the BBB and enter the plasma. This allowed for...
- whole tumor lysate, CMV antigen RNA and tumor-****ociated peptides like EGFRvIII. Dendritic cells can also be activated in vivo by making tumor cells express...
- tumor lysate, CMV antigen RNA and tumor ****ociated peptides for instance EGFRvIII. The initial studies showed that patients developed immune responses as...
- Furnari, F. B.; White, F. M.; et al. (2007). "Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy...
- treatment of Multiple myeloma. Tsutomu Nakazawa created KHYG-1 cells with EGFRvIII-specific CAR which inhibited the growth of glioblastoma cells in vitro...
- autologous CAR T-Cells against epidermal growth factor receptor variant III (EGFRvIII) in glioblastoma. "Combining CAR T cells with existing immunotherapies...
- "Sym004-induced EGFR elimination is ****ociated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models". J. Neurooncol. 138 (3): 489–498....